Insider · CIK 0001356256
Scott Dunseth Myers
Files at: ZNTL, HARP, CASC. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 AForm 4 → | Jun 18, 4:06 pm EDT | Zentalis Pharmaceuticals, Inc.ZNTL | 57,100 | — | — | 395,895 | — | |
| Mar 9, 2018 UForm 4 → | Mar 13, 6:07 pm EDT | Cascadian Therapeutics, Inc.CASC | 56,787 | — | — | 0 | — | plan? |
| Jan 11, 2018 FMForm 4 → | Jan 16, 5:26 pm EST | Cascadian Therapeutics, Inc.CASC | 13,929 | $3.92 | $13,442 | 56,787 | — | plan? |
| Aug 11, 2017 PForm 4 → | Aug 14, 5:12 pm EDT | Cascadian Therapeutics, Inc.CASC | 5,500 | $3.74 | $20,543 | 49,716 | +12.4% | plan? |
| May 12, 2017 PForm 4 → | May 16, 5:43 pm EDT | Cascadian Therapeutics, Inc.CASC | 2,800 | $4.00 | $11,192 | 44,216 | +6.76% | plan? |
| Mar 31, 2017 PForm 4 → | Apr 4, 5:39 pm EDT | Cascadian Therapeutics, Inc.CASC | 2,000 | $4.11 | $8,229 | 41,416 | +5.07% | plan? |
| Mar 20, 2017 PForm 4 → | Mar 21, 8:09 pm EDT | Cascadian Therapeutics, Inc.CASC | 1,000 | $3.93 | $3,927 | 39,416 | +2.60% | plan? |
| Jan 27, 2017 PForm 4 → | Jan 31, 4:55 pm EST | Cascadian Therapeutics, Inc.CASC | 20,500 | $3.76 | $77,039 | 38,416 | +114% | plan? |
| Aug 17, 2016 PForm 4 → | Aug 18, 5:16 pm EDT | Cascadian Therapeutics, Inc.CASC | 45,000 | $1.15 | $51,746 | 107,500 | +72.0% | plan? |
| Jun 28, 2016 PForm 4 → | Jun 28, 5:36 pm EDT | Cascadian Therapeutics, Inc.CASC | 62,500 | $0.80 | $50,000 | 62,500 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2018 DForm 4 → | Mar 13, 6:07 pm EDT | Cascadian Therapeutics, Inc.CASC | 1,038,610 | — | — | 0 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 5:54 pm EST | Cascadian Therapeutics, Inc.CASC | 250,000 | — | — | 250,000 | — | |
| Jan 11, 2018 MForm 4 → | Jan 16, 5:26 pm EST | Cascadian Therapeutics, Inc.CASC | 10,500 | — | — | 31,500 | — | |
| Nov 10, 2017 AForm 4 → | Nov 13, 8:00 pm EST | Cascadian Therapeutics, Inc.CASC | 6,300 | — | — | 6,300 | — | |
| Sep 18, 2017 AForm 4 → | Sep 20, 9:07 pm EDT | Cascadian Therapeutics, Inc.CASC | 75,500 | — | — | 15,500 | — | |
| Jan 11, 2017 AForm 4 → | Jan 13, 7:48 pm EST | Cascadian Therapeutics, Inc.CASC | 232,000 | — | — | 42,000 | — | |
| Apr 4, 2016 AForm 4 → | Apr 6, 5:07 pm EDT | Oncothyreon Inc.ONTY | 2,848,855 | — | — | 2,848,855 | — |